Alveolar Ridge and Soft Tissue Augmentation Using Graft From the Maxillary Tuberosity

January 4, 2023 updated by: Ahmed Hesham Mohamed, Ain Shams University

Localized Alveolar Ridge Reconstruction and Soft Tissue Augmentation Using a Triple Graft From the Maxillary Tuberosity Simultaneous With Immediate Implant Placement ( a Randomized Clinical Clinical Study)

In the study immediate implant is placed in the anterior region with autogenous bone grafting from the maxillary tuberosity in one group and in the other group immediate implant is placed with xenograft .IN both groups soft tissue grafting is done using connective tissue assessment of buccal bone thickness and soft tissue will be done 6 months post operative

Study Overview

Detailed Description

immediate implant will be placed in the anterior region with autogenous graft from the maxillary tuberosity and in the other group immediate implant will be laced with xenograft soft tissue grafting using sub-epithelial connective tissue will in both groups assessment of buccal bone thickness is the primary outcome of the study, while volumetric assessment of the soft tissue and patient satisfaction are the secondary and tertiary outcome the assessment of all outcome will be 6 months post operative the extraction socket in which the implant will be placed are class I&II

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Faculty of Dentistry Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Systemically healthy patients (American Society of Anesthesiologists I; ASA I).
  • Age range (20-40) years.
  • Good compliance with the plaque control instructions following initial therapy.
  • Patients diagnosed with bone defect in the maxillary anterior esthetic zone (class 1 & 2)
  • Availability for follow up and maintenance program.

Exclusion Criteria:

  • Peri apically infected teeth
  • Presence of smoking habit.
  • Presence of occlusal interferences.
  • Pregnant females.
  • Vulnerable group of patients (handicapped, mentally retarded and prisoners) (according to the recommendation of esthetical committee of Faculty of Dentistry Ain Shams University).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: immediate implant with bone graft (autogenous)
with immediate implant placement autogenous grafting using maxillary tuberosity will be done
the usage of maxillary tuberosity as source of autogenous graft supplying the needed cells for bone regeneration
Active Comparator: immediate implant with bonegraft (xenograft)
with immediate implant placement grafting with xenograft will be done
xenograft is bone graft material that is obtained from porcine, bovine or equine source

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
buccal bone thickness
Time Frame: at baseline and 6 months
measuring the buccal bone thickness using CBCT
at baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
volumetric assessment of soft tissue
Time Frame: 6 months post opertive
assessment of the soft tissue thickness after soft tissue augmentation using sub- epithelial connective tissue
6 months post opertive
patient satisfaction
Time Frame: after 6 month
questionnaire in which the scale is from (0 to 10) where 0 is completely unsatisfied and 10 totally satisfied
after 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hala Abu el ela, Prof, Faculty of Dentistry Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2021

Primary Completion (Actual)

November 23, 2022

Study Completion (Anticipated)

July 1, 2023

Study Registration Dates

First Submitted

December 11, 2022

First Submitted That Met QC Criteria

December 20, 2022

First Posted (Actual)

January 4, 2023

Study Record Updates

Last Update Posted (Actual)

January 5, 2023

Last Update Submitted That Met QC Criteria

January 4, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • no 948

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Immediate Implant Placement

Clinical Trials on maxillary tuberosity bone graft (autogenous graft)

3
Subscribe